Nu Skin Enterprises, Inc. (NYSE:NUS) to Issue Quarterly Dividend of $0.06

Key Points

• Nu Skin declared a quarterly dividend of $0.06 per share, payable December 9 to shareholders of record November 27. That equals $0.24 annually and a stated yield of 5.3%.
• The dividend appears covered by earnings: the payout ratio is 32%, with analysts expecting a lower 20.7% payout ratio based on next year’s forecast earnings. The company has reduced its dividend by an average of 0.3% annually over the past three years.
• Nu Skin missed quarterly estimates, reporting EPS of $0.10 versus $0.21 expected and revenue of $311.01 million versus $328.70 million expected.

Nu Skin Enterprises, Inc. (NYSE:NUS - Get Free Report) declared a quarterly dividend on Thursday, November 5th. Shareholders of record on Friday, November 27th will be given a dividend of $0.06 per share on Wednesday, December 9th. This represents a $0.24 dividend on an annualized basis and a yield of 5.3%. The ex-dividend date is Friday, November 27th.

Nu Skin Enterprises has decreased its dividend by an average of 0.3% per year over the last three years. Nu Skin Enterprises has a dividend payout ratio of 32.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Nu Skin Enterprises to earn $1.16 per share next year, which means the company should continue to be able to cover its $0.24 annual dividend with an expected future payout ratio of 20.7%.

Nu Skin Enterprises Price Performance

NYSE NUS opened at $4.53 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.24 and a current ratio of 1.98. The firm's 50 day moving average price is $4.77 and its 200-day moving average price is $6.30. Nu Skin Enterprises has a 52-week low of $4.45 and a 52-week high of $11.67. The company has a market cap of $220.26 million, a PE ratio of -1.01 and a beta of 0.92.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings data on Friday, November 6th. The company reported $0.10 EPS for the quarter, missing analysts' consensus estimates of $0.21 by ($0.11). The business had revenue of $311.01 million during the quarter, compared to the consensus estimate of $328.70 million. Nu Skin Enterprises had a positive return on equity of 6.58% and a negative net margin of 15.73%. Sell-side analysts forecast that Nu Skin Enterprises will post 0.82 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Pinnacle Wealth Planning Services Inc. acquired a new stake in shares of Nu Skin Enterprises in the 3rd quarter worth $38,000. Pinnacle Holdings LLC purchased a new position in Nu Skin Enterprises during the 2nd quarter worth $48,000. Corient Private Wealth LP acquired a new position in Nu Skin Enterprises during the 2nd quarter valued at about $54,000. Vise Technologies Inc. acquired a new position in Nu Skin Enterprises during the 3rd quarter valued at about $79,000. Finally, Public Employees Retirement System of Ohio acquired a new position in Nu Skin Enterprises during the 2nd quarter valued at about $132,000. Institutional investors own 82.84% of the company's stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.